全文获取类型
收费全文 | 18336篇 |
免费 | 1624篇 |
国内免费 | 393篇 |
专业分类
耳鼻咽喉 | 1110篇 |
儿科学 | 639篇 |
妇产科学 | 190篇 |
基础医学 | 3216篇 |
口腔科学 | 524篇 |
临床医学 | 1885篇 |
内科学 | 3240篇 |
皮肤病学 | 51篇 |
神经病学 | 3755篇 |
特种医学 | 237篇 |
外科学 | 733篇 |
综合类 | 1854篇 |
现状与发展 | 1篇 |
预防医学 | 1119篇 |
眼科学 | 152篇 |
药学 | 1036篇 |
11篇 | |
中国医学 | 407篇 |
肿瘤学 | 193篇 |
出版年
2024年 | 72篇 |
2023年 | 459篇 |
2022年 | 666篇 |
2021年 | 1110篇 |
2020年 | 1138篇 |
2019年 | 830篇 |
2018年 | 761篇 |
2017年 | 874篇 |
2016年 | 781篇 |
2015年 | 673篇 |
2014年 | 1129篇 |
2013年 | 1217篇 |
2012年 | 862篇 |
2011年 | 890篇 |
2010年 | 851篇 |
2009年 | 898篇 |
2008年 | 894篇 |
2007年 | 776篇 |
2006年 | 667篇 |
2005年 | 570篇 |
2004年 | 471篇 |
2003年 | 413篇 |
2002年 | 387篇 |
2001年 | 305篇 |
2000年 | 283篇 |
1999年 | 274篇 |
1998年 | 229篇 |
1997年 | 168篇 |
1996年 | 129篇 |
1995年 | 141篇 |
1994年 | 106篇 |
1993年 | 123篇 |
1992年 | 130篇 |
1991年 | 64篇 |
1990年 | 60篇 |
1989年 | 62篇 |
1988年 | 55篇 |
1987年 | 54篇 |
1986年 | 55篇 |
1985年 | 93篇 |
1984年 | 99篇 |
1983年 | 68篇 |
1982年 | 89篇 |
1981年 | 70篇 |
1980年 | 73篇 |
1979年 | 51篇 |
1978年 | 46篇 |
1977年 | 31篇 |
1976年 | 19篇 |
1975年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control 总被引:1,自引:0,他引:1
SUMMARY New data bearing on the neurobiological basis of REM sleep and on mechanisms of EEG synchronization/desynchronization are presented. The revision of the limit cycle reciprocal interaction model (LCRIM) of REM cycle control incorporates new information on monoamine inhibition of mesopontine cholinergic neurons and of cholinergic mechanisms promoting REM sleep. New data also show cortical slow-wave activity is controlled by thalamocortical neurons' membrane potential level, which, in turn, is strongly controlled during sleep by brainstem cholinergic input arising from REM-on neurons. This new knowledge leads to a neurobiologi-cally justified integration of the LCRIM and of the two-process model of sleep control. 相似文献
62.
Hippocampal extracellular levels of noradrenaline (NA), 5-hydroxytryptamine (5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) were monitored with the microdialysis technique in freely moving rats. In one experiment 30 min samples were collected during 24 h of continuous perfusion, and the monoamine output was compared to the behavioural activity state, as arbitrarily classified in three categories: sleep/rest, drowsiness and full alertness associated with complex behaviours. In the individual animal the hippocampal NA and 5-HT output showed pronounced fluctuations during the 24 h period, but the 30 min sampling times did not allow for a clear-cut correlation to behavioural activity state. However, the mean NA and 5-HT output for all animals during the dark period of the day was 43 and 38% higher, respectively, than during the light period, and the average NA and 5-HT levels in samples collected during periods of high behavioural activity was 34 and 45% higher, respectively, than during periods of rest or sleep. In contrast, there were no detectable changes in extracellular 5-HIAA. The selective serotonin uptake blocker indalpine, added to the perfusion fluid at 1 microM, increased the extracellular 5-HT levels 6-fold, with a similar correlation to behavioural activity state as without indalpine. In a second experiment the effect of handling and tail-pinch was studied in 15 min sample fractions. Gentle handling of the animals during the sampling period increased the hippocampal NA and 5-HT output by 32 and 72%, respectively, and a similar increase (63 and 48%) was obtained by application of tail-pinch. Maximum NA output was reached during the handling or tail-pinch period, whereas maximal 5-HT levels were detected in the subsequent 15 min sample fraction. No changes in extracellular 5-HIAA was observed. It is concluded (1) that intracerebral microdialysis provides a useful method for the study of extracellular NA and 5-HT in the hippocampal formation of conscious rats during active behaviour; (2) that there are substantial fluctuations in hippocampal NA and 5-HT output in freely moving rats which correlate with the light - dark cycle as well as with the activity state of the animals; (3) that the spontaneous variations in 5-HT output are maintained during reuptake blockade; and (4) that behavioural activation through gentle handling or tail-pinch elicits NA and 5-HT release. The present data support a role of the forebrain NA and 5-HT systems in behavioural state control and highlights the necessity of experimental designs in which the spontaneous fluctuations in transmitter release are controlled for in studies of, for example, drug effects on NA and 5-HT release in conscious animals. 相似文献
63.
Stenberg D Litonius E Halldner L Johansson B Fredholm BB Porkka-Heiskanen T 《Journal of sleep research》2003,12(4):283-290
Sleep deprivation (SD) increases extracellular adenosine levels in the basal forebrain, and pharmacological manipulations that increase extracellular adenosine in the same area promote sleep. As pharmacological evidence indicates that the effect is mediated through adenosine A1 receptors (A1R), we expected A1R knockout (KO) mice to have reduced rebound sleep after SD. Male homozygous A1R KO mice, wild-type (WT) mice, and heterozygotes (HET) from a mixed 129/C57BL background were implanted during anesthesia with electrodes for electroencephalography (EEG) and electromyography (EMG). After 1 week of recovery, they were allowed to adapt to recording leads for 2 weeks. EEG and EMG were recorded continuously. All genotypes had a pronounced diurnal sleep/wake rhythm after 2 weeks of adaptation. We then analyzed 24 h of baseline recording, 6 h of SD starting at light onset, and 42 h of recovery recording. Neither rapid eye movement sleep (REM sleep) nor non-REM sleep (NREMS) amounts differed significantly between the groups. SD for 6 h induced a strong NREMS rebound in all three groups. NREMS time and accumulated EEG delta power were equal in WT, HET and KO. Systemic administration of the selective A1R antagonist 8-cyclopentyltheophylline (8-CPT) inhibited sleep for 30 min in WT, whereas saline and 8-CPT both inhibited sleep in KO. We conclude that constitutional lack of adenosine A1R does not prevent the homeostatic regulation of sleep. 相似文献
64.
The purposes of this study were to apply the linear power versus inverse of time relationship to high-intensity upper-body
exercise and to assess the repeatability of the parameters critical power (CP) and anaerobic working capacity (AWC), using
limits of agreement (Bland and Altman 1986). Sixteen active male subjects (aged 20–34 years), performed two sets of five constant-power
exercises on an adapted cycle ergometer. There were no significant differences between mean estimates of CP [96 (16) W and
95 (17) W] and AWC [7457 (2011) J and 7608 (1684) J] from the first and second sets of bouts. Despite the lack of systematic
bias, there was evidence of large random error. Ratio limits of agreement for time to exhaustion during constant-power exercises
suggested that a repeat measurement might be expected in 95% of cases to be between 0.64 and 1.59 times the original measurement.
The 95% limits of agreement for CP were –15 W to +17 W. The ratio limits of agreement for AWC suggest that in 95% of cases
a repeat measurement might be between 0.57 and 1.67 times the original estimate. The results of this study suggest a poor
repeatability of constant-power upper-body exercises to exhaustion, which may contribute to a poor repeatability of CP and
AWC determined from the linear power versus inverse of time model.
Electronic Publication 相似文献
65.
This review was designed to determine from the best evidence whether there is an association between postmenopausal hormonal treatment and breast cancer risk. Also, if there is an association, does it vary according to duration and cessation of use, type of regimen, type of hormonal product or route of administration; whether there is a differential effect on risk of lobular and ductal cancer; and whether hormone treatment is associated with breast cancers that have better prognostic factors? Data sources for the review included Medline, the Cochrane Database of Systematic Reviews (Cochrane Library, 2005) and reference lists in the identified citations. Eligible citations addressed invasive breast cancer risk among postmenopausal women and involved use of the estrogen products with or without progestin that are used as treatment for menopausal symptoms. Abstracted data were demographic groupings, categories of hormone use, categories of breast cancer, two-by-two tables of exposure and outcome and adjusted odds ratios, relative risks (RRs) or hazard rates. Average estimates of risk were weighted by the inverse variance method, or if heterogeneous, using a random effects model. The average risk of invasive breast cancer with estrogen use was 0.79 [95% confidence interval (95% CI) = 0.61-1.02] in four randomized trials involving 12 643 women. The average breast cancer risk with estrogen-progestin use was 1.24 (95% CI = 1.03-1.50) in four randomized trials involving 19 756 women. The average risks reported in recent epidemiological studies were higher: 1.18 (95% CI = 1.01-1.38) with current use of estrogen alone and 1.70 (95% CI = 1.36-2.17) with current use of estrogen-progestin. The association of breast cancer with current use was stronger than the association with ever use, which includes past use. For past use, the increased breast cancer risk diminished soon after discontinuing hormones and normalized within 5 years. Reasonably adequate data do not show that breast cancer risk varies significantly with different types of estrogen or progestin preparations, lower dosages or different routes of administration, although there is a small difference between sequential and continuous progestin regimens. Epidemiological studies indicate that estrogen-progestin use increases risk of lobular more than ductal breast cancer, but the number of studies and cases of lobular cancer remains limited. Among important prognostic factors, the stage and grade in breast cancers associated with hormone use [corrected] do not differ significantly from those in non-users, but breast cancers in estrogen-progestin users are significantly more likely to be estrogen receptor (ER) positive. In conclusion, valid evidence from randomized controlled trials (RCTs) indicates that breast cancer risk is increased with estrogen-progestin use more than with estrogen alone. Epidemiological evidence involving more than 1.5 million women agrees broadly with the trial findings. Although new studies are unlikely to alter the key findings about overall breast cancer risk, research is needed, however, to determine the role of progestin, evaluate the risk of lobular cancer and delineate effects of hormone use on receptor presence, prognosis and mortality in breast cancer. 相似文献
66.
Therapy for rhinitis improves sleep quality and symptoms of daytime sleepiness. This improvement with therapy may be secondary to anti-inflammatory effects, leading to a reduction of inflammatory mediators, or to a mechanical reduction of congestion directly leading to improvement in sleep disturbance. We combined our data from 3 placebo-controlled studies of intranasal corticosteroids in patients with perennial rhinitis to determine whether a correlation between the reduction of congestion and improved sleep and daytime somnolence existed. The pooled data of budesonide, flunisolide, and fluticasone demonstrated significantly decreased nasal congestion, sleep problems, and sleepiness in treated patients. The data demonstrated a correlation between a reduction in nasal congestion and an improvement of sleep (P < .01) and daytime somnolence (P = .01). Thus, topical intranasal corticosteroids should be used to decrease nasal congestion and to improve sleep and daytime somnolence in patients manifesting these symptoms. 相似文献
67.
Bilzon JL Murphy JL Allsopp AJ Wootton SA Williams C 《European journal of applied physiology》2002,87(4-5):318-326
Carbohydrate (CHO) ingestion during short-term recovery from prolonged running has been shown to increase the capacity for
subsequent exercise in a warm environment. The aim of this study was to examine the effects of the amount of glucose given
during recovery on substrate storage and utilisation during recovery and subsequent exercise in a warm environment. A group
of 11 healthy male volunteers took part in two experiments in a controlled warm environment (35°C, 40% relative humidity),
1 week apart. On each occasion the subjects completed two treadmill runs (T1 and T2) at a speed equivalent to 60% of maximal
oxygen uptake, for 90 min, until they were fatigued, or until aural temperature (T
aur) reached 39°C. The two runs were separated by a 4 h recovery period (REC), during which subjects consumed 55 g of naturally
enriched [U-13C]-glucose in the form of a 7.5% carbohydrate-electrolyte solution (CES, mass of solution 667 g) immediately after T1. The
subjects then consumed either: the same quantity of CES, or an equivalent volume of an electrolyte placebo, at 60, 120 and
180 min during REC, providing a total of 220 g (C220) or 55 g (C55) of [U-13C]-glucose, respectively. Expired gases were collected at 15 min intervals during exercise and 60 min intervals during REC,
for determination of total CHO and fat oxidation by indirect respiratory calorimetry, and orally ingested [U-13C]-glucose oxidation, estimated from the 13C:12C ratio of expired CO2. Substrate metabolism did not differ between conditions during T1. Despite the fact that total CHO (P<0.05) and ingested glucose oxidation (P<0.01) were greater during REC of the C220 condition, glycogen synthesis was estimated to be approximately fivefold greater
(P<0.01) than in the C55 condition. During T2 the rate of total CHO oxidation was higher (P<0.01) and total fat oxidation lower (P<0.01) at all times during the C220 compared to the C55 condition. The greater CHO oxidation during C220 appeared to be met
from ingested sources, as the rate of [U-13C]-glucose oxidation was greater (P<0.01) at all times during T2, compared to C55. Whilst more of the ingested substrate remained unoxidised on completion of
T2 during C220, exercise duration was similar in the two experimental conditions, and was limited by thermoregulatory incapacity
(T
aur>39°C) rather than substrate availability per se.
Electronic Publication 相似文献
68.
Satoshi Takahashi Dawn D. Tooley Levente Kapás Jidong Fang Jerome M. Seyer James M. Krueger 《Pflügers Archiv : European journal of physiology》1995,431(2):155-160
Tumor necrosis factor (TNF) is a cytokine that possesses many biological activities, including enhancement of non-rapid-eye-movement sleep (NREMS). The role of endogenous TNF in the regulation of spontaneous sleep is unknown. If TNF is involved in sleep regulation, then reduction of endogenous TNF should suppress spontaneous sleep. A soluble TNF-binding protein I (TNF-BP I) and a synthetic fragment of TNF-BP I, TNF-R-(159–178), that contains the biologically active region of TNF-BP I, were used. These substances bind TNF and possess TNF-inhibitory activity; their effects on rabbit sleep after intracerebroventricular injection were determined across a 6-h recording period. Two doses of TNF-BP I (0.05 g and 0.5 g) were administered; the higher dose of TNF-BP I significantly decreased NREMS. Four doses of TNF-R-(159–178) (0.25 g, 2.5 g, 25 g and 50 g) were used. The 25 g and 50 g doses significantly suppressed NREMS. The highest dose (50 g) also decreased REM sleep. These results are consistent with the hypothesis that endogenous brain TNF is involved in the regulation of normal sleep. 相似文献
69.
A developmentally immature sleep pattern has been identified in infants with a recent history of an unexplained life-threatening episode of sleep apnoea who are considered at risk for SIDS. In these infants there is a persistence of Sleep Onset REM Periods (SOREMPS) after prolonged wakefulness when compared to controls matched for age, sex, birthweight and race. This sleep characteristic has not been previously reported. 相似文献
70.
SUMMARY Epidemiological data indicate a link between sleep-disordered breathing and elevation of arterial pressure. Previous studies suggest increased activity of the sympathetic nervous system in patients with sleep apnoea. The response of muscle sympathetic nerve activity was further investigated in normal, awake subjects following exposure to 20 minutes of asphyxia. Sympathetic nerve traffic increased during exposure and remained elevated even after the return to room air breathing. These findings raise the possibility that this sustained elevation of sympathetic nerve traffic could play a role in the development of daytime hypertension in patients with sleep-disordered breathing. 相似文献